{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:37:30Z","timestamp":1792255050796,"version":"4.4.0"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamainternmed.2019.0306","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T11:01:45Z","timestamp":1557745305000},"page":"881","source":"Crossref","is-referenced-by-count":160,"title":["Clinical Evaluation of Human Papillomavirus Screening With p16\/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program"],"prefix":"10.1001","volume":"179","author":[{"given":"Nicolas","family":"Wentzensen","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Bremer","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Poitras","sequence":"additional","affiliation":[{"name":"Kaiser Permanente The Permanente Medical Group Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Tokugawa","sequence":"additional","affiliation":[{"name":"Kaiser Permanente The Permanente Medical Group Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Goldhoff","sequence":"additional","affiliation":[{"name":"Kaiser Permanente The Permanente Medical Group Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie D.","family":"Kingery","sequence":"additional","affiliation":[{"name":"Kaiser Permanente The Permanente Medical Group Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiranjit K.","family":"Grewal","sequence":"additional","affiliation":[{"name":"Kaiser Permanente The Permanente Medical Group Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Locke","sequence":"additional","affiliation":[{"name":"Kaiser Permanente The Permanente Medical Group Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Kinney","sequence":"additional","affiliation":[{"name":"Global Coalition Against Cervical Cancer, Arlington, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Lorey","sequence":"additional","affiliation":[{"name":"Kaiser Permanente The Permanente Medical Group Regional Laboratory, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"ioi190015r1","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/ijc.v140.10","article-title":"Eurogin 2016 roadmap: how HPV knowledge is changing screening practice.","volume":"140","author":"Wentzensen","year":"2017","journal-title":"Int J Cancer"},{"issue":"8","key":"ioi190015r2","doi-asserted-by":"publisher","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"ioi190015r3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1470-2045(12)70568-5","article-title":"Triage of HPV-positive women in cervical cancer screening.","volume":"14","author":"Wentzensen","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"ioi190015r4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ijc.31261","article-title":"Eurogin roadmap 2017: triage strategies for the management of HPV-positive women in cervical screening programs.","volume":"143","author":"Cuschieri","year":"2018","journal-title":"Int J Cancer"},{"key":"ioi190015r5","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening.","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J Clin Virol"},{"issue":"2","key":"ioi190015r6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/LGT.0000000000000103","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.","volume":"19","author":"Huh","year":"2015","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"ioi190015r7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"10","key":"ioi190015r8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.v131.10","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"issue":"8","key":"ioi190015r9","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/ijc.28514","article-title":"Interlaboratory variation in the performance of liquid-based cytology: insights from the ATHENA trial.","volume":"134","author":"Wright","year":"2014","journal-title":"Int J Cancer"},{"issue":"10","key":"ioi190015r10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.","volume":"9","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol"},{"issue":"2","key":"ioi190015r11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S1470-2045(12)70529-6","article-title":"Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.","volume":"14","author":"Carozzi","year":"2013","journal-title":"Lancet Oncol"},{"key":"ioi190015r12","article-title":"Five-year risk of cervical precancer following p16\/Ki-67 dual-stain triage of HPV-positive women [published online October 11, 2018].","author":"Clarke","journal-title":"JAMA Oncol"},{"issue":"12","key":"ioi190015r13","doi-asserted-by":"publisher","first-page":"djv257","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 Dual stain cytology for detection of cervical precancer in HPV-positive women.","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"ioi190015r14","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ioi190015r15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","article-title":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial.","volume":"144","author":"Wright","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"16","key":"ioi190015r16","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"ioi190015r17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.0006-341X.2000.00345.x","article-title":"Comparisons of predictive values of binary medical diagnostic tests for paired designs.","volume":"56","author":"Leisenring","year":"2000","journal-title":"Biometrics"},{"issue":"5","key":"ioi190015r18","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"7","key":"ioi190015r19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"issue":"12","key":"ioi190015r20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/cncy.21473","article-title":"Interobserver reproducibility and accuracy of p16\/Ki-67 dual-stain cytology in cervical cancer screening.","volume":"122","author":"Wentzensen","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"1-2","key":"ioi190015r21","first-page":"109","article-title":"A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides.","volume":"32","author":"Grabe","year":"2010","journal-title":"Cell Oncol"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamainternalmedicine\/article-pdf\/179\/7\/881\/17690719\/jamainternal_wentzensen_2019_oi_190015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T11:02:31Z","timestamp":1561978951000},"score":1,"resource":{"primary":{"URL":"http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/jamainternmed.2019.0306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2019.0306","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}